ProShares UltraPro NASDAQ Biotechnology (NASDAQ:UBIO) shares traded up 2.2% on Friday . The stock traded as high as $22.43 and last traded at $22.27, 500 shares traded hands during mid-day trading. A decline of 99% from the average session volume of 43,751 shares. The stock had previously closed at $21.80.

The firm has a 50-day moving average of $22.00 and a two-hundred day moving average of $24.88.

A hedge fund recently raised its stake in ProShares UltraPro NASDAQ Biotechnology stock. Tower Research Capital LLC TRC raised its stake in ProShares UltraPro NASDAQ Biotechnology (NASDAQ:UBIO) by 539.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,735 shares of the company’s stock after purchasing an additional 13,275 shares during the quarter. Tower Research Capital LLC TRC owned about 1.37% of ProShares UltraPro NASDAQ Biotechnology worth $407,000 at the end of the most recent quarter.

See Also: Overbought

Receive News & Ratings for ProShares UltraPro NASDAQ Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraPro NASDAQ Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.